CASH CD. Gamma-hydroxybutyrate: an overview of the pros and cons for it being a neurotrnsmitter and/or a useful therapeutic agent. Neurosci Biobehav Rev 1994 18:291-304.
CHIN MY, KREUTZER RA, DYER JE. Acute poisoning from gamma-hydroxybutyrate in California. West J Med 1992 156:380-384.
DUCHAINE D. Underground steroid handbook update 1992, Power Distributors, Marina del Rey, California, USA. 1992.
GERRA G, CACCAVARI R, FONTANESI B, MARCATO A, FERTONANI AFFINI G, MAESTRI D, AVANZINI P, LECCHINI R, DELSIGNORE R, MUTTI A. Flumazenil effects on growth hormone response to gamma-hydroxybutyric acid. Int Clin Psychopharmacol 1994 9:211-215.
GERRA G, CACCAVARI R, FONTANESI B, FERTONANI AFFINI G, MAESTRI D, AVANZINI P, ZAIMOVIC A, FRANCHINI D, DELSIGNORE R. Naxolone and metergoline effects on growth hormone response to gamma-hydroxybutyric acid. Int Clin Psychopharmacol 1995 10:245-250.
LAMMERS GJ, ARENDS J, DECLERCK AC, FERRARI MD, SCHOUWINK G, TROOST J. Gammahydroxybutyrate and narcolepsy: a double-blind pacebo-controlled study. Sleep 1993 16:216-220.
LUBY S, JONES J, ZALEWSKI A. GHB use in South Carolina. Am J Public Health 1992 82:128.
MYRENFORS P. Tio förgiftningar med gammahydroxybutyrat. Endogen substans använd i kroppsbyggarkretsar. Läkartidningen 1996 93:1973-1974.
NIGHTINGALE SL. From the food and drug administration: Warning about GHB. JAMA 1991 265:1802.